A systematic review of the association of Type I diabetes with sensorineural hearing loss.

Autor: Mittal R; Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America., McKenna K; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America.; Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, United States of America., Keith G; School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin, United States of America., Lemos JRN; Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America., Mittal J; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, United States of America., Hirani K; Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2024 Feb 09; Vol. 19 (2), pp. e0298457. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).
DOI: 10.1371/journal.pone.0298457
Abstrakt: Objectives: Type 1 diabetes (T1D) has been associated with several comorbidities such as ocular, renal, and cardiovascular complications. However, the effect of T1D on the auditory system and sensorineural hearing loss (SNHL) is still not clear. The aim of this study was to conduct a systematic review to evaluate whether T1D is associated with hearing impairment.
Methods: The databases PubMed, Science Direct, Scopus, and EMBASE were searched in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria. Three reviewers independently screened, selected, and extracted data. The Joanna Briggs Institute (JBI) Critical Appraisal Tools for Analytical cross-sectional and case-control studies were used to perform quality assessment and risk of bias analysis on eligible studies.
Results: After screening a total of 463 studies, 11 eligible original articles were included in the review to analyze the effects of T1D on the auditory system. The included studies comprised cross-sectional and case-control investigations. A total of 5,792 patients were evaluated across the 11 articles included. The majority of the studies showed that T1D was associated with hearing impairment compared to controls, including differences in PTAs and OAEs, increased mean hearing thresholds, altered acoustic reflex thresholds, and problems with the medial olivocochlear (MOC) reflex inhibitory effect. Significant risk factors included older age, increased disease duration, and higher HbA1C levels.
Conclusions: This systematic review suggests that there is a correlation between T1D and impairment on the auditory system. A multidisciplinary collaboration between endocrinologists, otolaryngologists, and audiologists will lead to early detection of hearing impairment in people with T1D resulting in early intervention and better clinical outcomes in pursuit of improving the quality of life of affected individuals.
Registration: This systematic review is registered in PROSPERO (CRD42023438576).
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2024 Mittal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje